{
  "ticker": "NUC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972382",
  "id": "02972382",
  "pages": 8,
  "price_sensitive": true,
  "date": "20250724",
  "time": "1451",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m3g9259fj03w.pdf",
  "summary": "Here\u2019s the material information extracted from the ASX announcement, formatted concisely:\n\n### **Quarterly Report (Appendix 4C)**  \n- **Revenue**:  \n  - Record quarterly revenue of **$6.3m** (up **167% pcp**).  \n  - FY25 revenue **$22.8m** (up **110% pcp**).  \n  - ANZ retail sales **$1.7m** (up **32% pcp**; 36% MAT growth vs. 2% infant formula market growth).  \n  - China CBEC sales **$2.3m** (up **114% pcp**).  \n  - Vietnam sales **$0.6m** (FY25 total: **$1.6m**).  \n\n- **Operational Highlights**:  \n  - Entered **exclusive Sales Agency Agreement** with Brauer/H&S Brands (incremental **$0.1m** revenue).  \n  - New product (Oli6\u00ae Grow) contributed **$0.3m** in Q4.  \n\n- **Financial Position**:  \n  - Closing cash balance: **$3.6m**.  \n  - Net operating cash outflow: **$0.1m** (improved from prior quarter\u2019s **$1.1m** outflow).  \n  - Unused financing facilities: **$0.6m**.  \n  - Estimated funding runway: **49 months** (based on current burn rate).  \n\n- **Payments to Related Parties**: **$903k** (directors\u2019 fees, H&S marketing fees).  \n\n**Key Takeaways**: Strong revenue growth across all channels, improved cash flow trajectory, and strategic diversification via Vietnam and agency agreements. No immediate capital raising signaled.",
  "usage": {
    "prompt_tokens": 4977,
    "completion_tokens": 370,
    "total_tokens": 5347,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-24T05:51:27.356633"
}